Concepedia

Nathalie Largeron

NL

26

Publications

1.1K

Citations

21

H-Index

2006

Active since

Affiliations

Sanofi (France)(Current)

Regione Lazio

National Research Council

Institute for Research on Population and Social Policies

Sanofi (United Kingdom)

Nathalie Largeron is an author at Sanofi (France) specializing in vaccination, medicine, and health economics.

Top concepts

Publications per year

2006–2021

26

Publications

26

The economic value of vaccination: why prevention is wealth

Vanessa Rémy, Nathalie Largeron, Sibilia Quilici et al. · Journal of Market Access & Health Policy · 2015 · 114 citations · Full text

, , +20

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: a cost-effectiveness analysis

Shalini Kulasingam, Stève Bénard, Ruanne V. Barnabas et al. · Cost Effectiveness and Resource Allocation · 2008 · 84 citations · Full text

Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France

Christine Bergeron, Nathalie Largeron, Ruth McAllister et al. · International Journal of Technology Assessment in Health Care · 2008 · 82 citations

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

Rémi Marty, Stéphane Roze, Xavier Bresse et al. · BMC Cancer · 2013 · 76 citations · Full text

Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe

M. Uhart, Hélène Bricout, E. Clay et al. · Human Vaccines & Immunotherapeutics · 2016 · 57 citations · Full text

, , +17

Rows per page

1–5 of 26